Search research articles
Contact Us
Filters
Showing results (471-480 of 473) with videos related to
Page
of 48
Sort By:
You have reached the last page of results.
This site can display upto 473 results.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A Philip, Jill Lacy, Fabienne Portales, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F Bannoura, Husain Yar Khan, Amro Aboukameel, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma
Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Page
of 48
Search research articles
Search
Showing results (471-480 of 473) with videos related to
Sort By:
Page
of 48
You have reached the last page of results.
This site can display upto 473 results.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A Philip, Jill Lacy, Fabienne Portales, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F Bannoura, Husain Yar Khan, Amro Aboukameel, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma
Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Page
of 48